<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-30T05:19:14Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/5194" metadataPrefix="dim">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/5194</identifier><datestamp>2022-02-28T23:42:08Z</datestamp><setSpec>com_10259_4365</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_4366</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="491" confidence="500" orcid_id="">Rubio Antolin, Ana Rosa</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="723993db-eafe-481b-b4ee-71856c5e6268" confidence="500" orcid_id="">Fidalgo Zorrilla, Jairo</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="c32f0548-ba52-4a37-a111-e68423c7b368" confidence="500" orcid_id="">Martin Vargas, Judit</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="435" confidence="500" orcid_id="">Pérez Arnáiz, Cristina</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="20" confidence="500" orcid_id="">Alonso de la Torre, Sara</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="686e3c46-a69c-4fbe-9b7a-e05265bbac4e" confidence="500" orcid_id="">Biver, Tarita</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="162" confidence="500" orcid_id="">Espino Ordóñez, Gustavo</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="83" confidence="500" orcid_id="">Busto Vázquez, Natalia</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="217" confidence="500" orcid_id="">García Ruiz, Begoña</dim:field>
<dim:field mdschema="dc" element="date" qualifier="accessioned">2019-12-16T10:32:02Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="available">2019-12-16T10:32:02Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="issued">2020-02</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="issn">0162-0134</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/10259/5194</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="doi">10.1016/j.jinorgbio.2019.110885</dim:field>
<dim:field mdschema="dc" element="description" qualifier="abstract" lang="en">The synthesized 2-(hydroxy-1-naphtyl)imidazo-[4,5-f][1,10]phenanthroline (HNAIP) ligand and its new iridium ([Ir(ppy)2(HNAIP)]Cl) and rhodium ([Rh(ppy)2(HNAIP)]Cl) complexes, being ppy = 2-phenylpiridinate, show cytotoxic effects in SW480 (colon adenocarcinoma) and A549 (epithelial lung adenocarcinoma) cells. They all are cytotoxic in the tested cell lines. HNAIP and [Rh(ppy)2(HNAIP)]+ are the most cytotoxic, whereas [Ir(ppy)2(HNAIP)]+ displays negligible cytotoxicity towards A549 cells and moderate activity towards SW480. The interaction of all three compounds with Bovine Serum Albumin (BSA), l-glutathione reduced (GSH), nicotinamide adenine dinucleotide (NADH) and DNA was studied to explain the differences found in terms of cytotoxicity. None of them are able to interact with BSA, thus excluding bioavailability due to plasma protein interaction as the possible differentiating factor in their biological activity. By contrast, small differences have been observed regarding DNA interaction. In addition, taking advantage of the emission properties of these molecules, they have been visualized in the cytoplasmic region of A549 cells. Inductively coupled plasma mass spectrometry (ICP-MS) experiments show, in turn, that the internalization ability follow the sequence [Rh(ppy)2(HNAIP)]+ > [Ir(ppy)2(HNAIP)]+ > cisplatin. Therefore, it seems clear that the cellular uptake by tumour cells is the key factor affecting the different cytotoxicity of the metal complexes and that this cellular uptake is influenced by the hydrophobicity of the studied complexes. On the other hand, preliminary catalytic experiments performed on the photo-oxidation of GSH and some amino acids such as l-methionine (Met), l-cysteine (Cys) and l-tryptophan (Trp) provide evidence for the photocatalytic activity of the Ir(III) complex in this type of reactions.</dim:field>
<dim:field mdschema="dc" element="description" qualifier="sponsorship" lang="es">“la Caixa” Banking Foundation (LCF/PR/PR12/11070003), Ministerio de Ciencia, Innovación y Universidades (RTI2018-102040-B-100 and RTI2018-100709-B-C21), Junta de Castilla y León (BU305P18, FEDER Funds)</dim:field>
<dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
<dim:field mdschema="dc" element="language" qualifier="iso">eng</dim:field>
<dim:field mdschema="dc" element="publisher" lang="es">Elsevier</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="ispartof">Journal of Inorganic Biochemistry. 2019,  V. 203, 110885</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="publisherversion">https://doi.org/10.1016/j.jinorgbio.2019.110885</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID">info:eu-repo/grantAgreement/MICINN/RTI2018-102040-B-100</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID">info:eu-repo/grantAgreement/MICINN/RTI2018-100709-B-C21</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID">info:eu-repo/grantAgreement/JCyL/BU305P18</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID">info:eu-repo/grantAgreement/FundaciónLaCaixa/LCF/PR/PR12/11070003</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="uri" lang="*">http://creativecommons.org/licenses/by-nc-nd/4.0/</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="holder" lang="*">Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="accessRights">info:eu-repo/semantics/openAccess</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">2-(hydroxy-1-naphtyl)imidazo-[4,5-f]</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">[1,10]phenanthroline</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Iridium</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Rhodium</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Cellular test</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">DNA</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Photo-catalysis</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="other" lang="es">Bioquímica</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="other" lang="es">Química inorgánica</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="other" lang="en">Biochemistry</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="other" lang="en">Chemistry, Inorganic</dim:field>
<dim:field mdschema="dc" element="title" lang="en">Biological activity and photocatalytic properties of a naphthyl-imidazo phenanthroline (HNAIP) ligand and its [Ir(ppy)2(HNAIP)]Cl and [Rh(ppy)2(HNAIP)]Cl complexes</dim:field>
<dim:field mdschema="dc" element="type" lang="en">info:eu-repo/semantics/article</dim:field>
<dim:field mdschema="dc" element="type" qualifier="hasVersion">info:eu-repo/semantics/acceptedVersion</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>